Articles tagged with Type 2 Diabetes
Researchers found that metformin treatment does not have a positive effect on the brain development of offspring mice. The study suggests that the maternal metabolic state is crucial in determining the impact of metformin on the child's health.
Recent medications for Type 2 diabetes and weight loss have positive effects on cardiovascular and kidney health but are not always prescribed or accessible to those who need them. The studies highlight the need to address barriers to access and equity, particularly among Black adults with severe obesity.
A recent literature review discusses the underlying mechanisms of type 2 diabetes, including insulin resistance and b-cell failure. The review also explores potential therapeutic strategies, such as replenishing and regenerating b-cells, pancreas transplants, and stem cell-derived b-cells.
Researchers found that Kallistatin expression increases after weight loss, improving hepatic insulin sensitivity in obese mice. This protein may be an interesting therapeutic target for treating obesity and type 2 diabetes.
Researchers identified six novel protein biomarkers associated with incident coronary heart disease in individuals with and without type 2 diabetes. The study found that these biomarkers may offer potential new approaches to prevention and treatment of CHD.
A landmark study stratifies people with type 2 diabetes using routine variables to visualize metabolic diversity. The algorithm identifies different subtypes of the disease, which can help in targeted prevention and treatment.
Research reveals metformin treatment does not benefit offspring brain development despite positive effects on pregnant animals. Maternal metabolic state plays a crucial role in shaping the outcomes.
A Stanford Medicine study found that metformin stimulates production of lac-phe, an anti-hunger molecule abundant after exercise, leading to moderate weight loss in mice and humans. Understanding how metformin works through this pathway may lead to new strategies for lowering body mass and improving health.
Researchers have identified a gene responsible for the development of starvation-induced fatty liver in cavefish, which are able to protect their liver due to reduced fat accumulation. This genetic basis has implications for understanding and addressing liver conditions in humans, including Type 2 diabetes and obesity.
A new synthesis method for semaglutide developed by an international team of researchers may help alleviate the global shortage of the drug, which is used to treat diabetes and aid in weight loss. The method uses glycosylation, resulting in ten-fold higher yields compared to existing processes.
A new study published in the journal Stroke found that African American veterans with PTSD had a significantly higher risk of re-hospitalization after a stroke compared to those without PTSD. This was not observed among white veterans. The study highlights the importance of targeted care for high-risk populations and reducing modifiabl...
A new analysis shows that tirzepatide effectively reduces body weight across different BMI subgroups, achieving significant weight loss of 5% or more in up to 100% of participants. The treatment also demonstrated superior weight reduction compared to placebo in patients with type 2 diabetes.
New research shows tirzepatide consistently reduces bodyweight and waist circumference, with greater reductions in participants with longer disease durations. Tirzepatide also achieves higher weight loss targets and reduces waist circumference more significantly than placebo across all disease duration categories.
A recent study found that many people with type 2 diabetes know little about their condition, highlighting the need to improve communication and disease knowledge. The study revealed significant gaps in knowledge, particularly regarding blood sugar monitoring and late-stage complications like ketoacidosis.
A pilot study found that personalized dietary advice based on genetic information reduced blood glucose levels more effectively than standard coaching. The study suggests genetically-informed diets could be an effective intervention for preventing type 2 diabetes.
A recent study identified 12 genetic clusters associated with type 2 diabetes, explaining differences in clinical presentations among diverse populations. The clusters related to fat metabolism and cholesterol levels also shed light on why certain groups are more susceptible to the disease.
A study of 247,000 UK residents found a strong association between habitual short sleep duration and the development of type 2 diabetes. Even among those with healthy diets, short sleep duration was associated with an increased risk of developing the condition.
A new study from Uppsala University found that adults who sleep only three to five hours a day are at higher risk of developing type 2 diabetes. Chronic sleep deprivation cannot be compensated by healthy eating alone.
Research links low birthweight (<2.5 kg/5 lbs 8oz) to increased risk of early type 2 diabetes (59 years or younger) when combined with overweight at aged 20 years, with a 10 times greater risk compared to normal weight peers.
Researchers discovered a potential treatment for Alzheimer's disease also prevents Type 2 diabetes by blocking the formation of toxic IAPP clusters. A synthetic peptide was shown to bind and neutralize these clusters, keeping beta cells alive.
A novel AI-driven model developed by Maytal Saar-Tsechansky predicts which patients are most likely to benefit from preventive treatment for Type II diabetes. The model, trained on electronic health records of 89,191 prediabetic patients, improved both health and economic efficiency, enabling data-driven allocation of resources.
A novel study in mice with diet-induced obesity demonstrates that the knock-out of inceptor enhances glucose regulation, prompting its exploration as a drug target for type 2 diabetes treatment. Inhibiting inceptor function may enhance insulin signaling, required for beta cell function and survival.
A 12-year study found that bariatric surgery significantly improves blood glucose control and reduces the need for diabetes medications. Patients who underwent bariatric surgery experienced greater weight loss and higher rates of complete diabetes remission compared to those receiving medical therapy.
A 12-year study published in JAMA found that bariatric surgery significantly improved blood glucose control and type 2 diabetes remission compared to medical management alone. Participants who underwent bariatric surgery experienced greater weight loss, reduced medication use, and higher rates of diabetes remission.
The study found that bariatric surgery improved blood sugar control and reduced diabetes medication use more effectively than medical and lifestyle modifications. Bariatric surgery also led to superior cholesterol and triglyceride levels, which can contribute to fewer heart attacks and strokes.
After 7 to 12 years of follow-up, bariatric surgery outperformed medical/lifestyle intervention in achieving superior glycemic control with reduced medication use and higher rates of diabetes remission. Individuals who underwent bariatric surgery had better long-term management of their type 2 diabetes.
A new mouse study reveals that the gut microbiome interacts with the loss of female sex hormones to exacerbate metabolic disease. The research suggests that the gut microbiome contributes to weight gain, fat in the liver, and inflammation, particularly in women after menopause.
A new study from Edith Cowan University found that a blood test using joint cumulative high-sensitivity C-reactive protein and monocyte to high-density lipoprotein ratio can predict type 2 diabetes risk more effectively. Females were most at risk with significant interaction between MHR and CRP observed.
Healthcare providers must prioritize patient experience to improve diabetes care. This includes explaining treatment options and considering each patient's level of health literacy and cultural background.
A study found that 670 nanometres of red light stimulated energy production within mitochondria, leading to increased glucose consumption and a 27.7% reduction in blood glucose levels. This non-invasive technique has the potential to impact diabetes control by reducing damaging fluctuations of blood glucose.
A study has identified 1,289 genetic markers associated with Type 2 diabetes, including 145 newly discovered markers. The research provides risk scores for diabetes complications and suggests potential genetic targets for new treatments.
Researchers from Pusan National University discovered a link between diabetes and periodontitis, showing pro-inflammatory cytokines rise in classical monocytes. The study highlights the systemic impact of these conditions on immune regulation and suggests a potential therapeutic target to reduce diabetes risk.
Researchers from Osaka University found that gargling with an antiseptic mouthwash can reduce periodontitis-related bacteria in patients with type 2 diabetes. This simple method may improve the lives of people with periodontitis-linked diseases such as diabetes, dementia, and cardiovascular disease.
A study published in the Journal of the American College of Surgeons found that gastric bypass surgery results in high rates of Type-2 diabetes remission five years after the operation, even after patients regain a significant amount of weight. In contrast, patients who underwent sleeve gastrectomy and regained their weight were five t...
A new study finds that Type 2 diabetes causes intervertebral discs to become stiffer and change shape earlier than normal. This leads to a compromised ability to withstand pressure, highlighting the need for preventative and therapeutic strategies.
A new American Heart Association scientific statement emphasizes the need for increased awareness of heart disease as a major health risk for women, particularly those with pregnancy complications. Early detection and treatment of risk factors may help prevent future heart attack, heart failure, and stroke.
Research found that boosting weekly total physical activity by just over an hour is associated with a 33% lower risk of progression to chronic kidney disease. The study also showed that longer bouts of moderate-intensity exercise, even those below 10 minutes, contribute to better outcomes.
A new study published in the American Heart Association journal Hypertension found that tirzepatide significantly lowered systolic blood pressure levels in nearly 500 adults with obesity. The results suggest treating obesity with this weight loss medication may be an effective strategy for preventing or treating high blood pressure.
Researchers found that people with Type 2 diabetes have higher levels of AGEs, leading to more viscoelastic liver tissue, which increases the risk of liver cancer. The study suggests new screening guidelines for this population, potentially improving early detection and treatment.
A recent study published in PNAS suggests that impaired macrophage function plays a key role in the development of type 2 diabetes in obese individuals. The research found that collagen breakdown is handled by macrophages, which become deactivated in obesity and insulin resistance, leading to the accumulation of collagen fragments.
Researchers at Karolinska Institutet developed a method to study liver function and disease using the cornea of mice eyes. They transplanted liver cells into the eyes, creating a non-invasive platform to monitor liver health over time.
Researchers found that SGLT2 inhibitors reduced kidney stone rates by 30% compared to GLP1 agonists and 25% compared to DPP4 inhibitors. The study included data from 716,406 adults with type 2 diabetes who took these medications.
A new study led by University of Bristol researchers found that weight loss in people with type 2 diabetes can alter levels of cancer-related chemicals circulating in the blood. Nine cancer-related proteins were changed by the weight loss intervention, suggesting a potential reduction in cancer risk.
A new review suggests that female reproductive characteristics, such as early menstruation and polycystic ovary syndrome, may contribute to later metabolic dysfunction. The study highlights the importance of screening for reproductive risk factors to aid in prevention or treatment of chronic metabolic diseases.
A international academic consortium has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease risk in people with type 2 diabetes. The standout biomarker was N-terminal pro b-type natriuretic peptide (NT-proBNP), which is currently used to monitor heart failure status in patients.
A recent study by University of Missouri researcher Mansoo Yu found that online weight loss interventions with counseling and social support are effective for middle-aged adults with obesity. The study identified two key features: professional health coaching and access to social support from other users, which led to significant long-...
A nationwide study from Karolinska Institutet found that GLP1 agonists like Ozempic reduce the risk of cirrhosis and liver cancer in people with type 2 diabetes and chronic liver disease. Those who continued taking the medication for ten years were half as likely to develop severe liver disease.
A global study review found negative indirect impacts of the pandemic on people with diabetes, including a rise in non-COVID-19-related deaths, diabetic ketoacidosis among children and adolescents, and sight loss. Pediatric ICU admissions were also significantly increased.
A new study found that only 6% of people with type 2 diabetes achieved diabetes remission solely through weight loss by about eight years after diagnosis. People who initially lost a significant amount of weight in the first year were more likely to achieve sustained remission.
Participants with diabetes remission had a 33% lower rate of CKD and a 40% lower rate of CVD compared to those without remission. The magnitude of risk reduction was greatest for participants with longer-term remission.
Researchers found that participants who achieved diabetes remission through weight loss had a 40% lower rate of cardiovascular disease and 33% lower rate of chronic kidney disease. The study, led by Professor Edward Gregg, monitored over 5,000 patients for 12 years.
A new study found that young adults who reported higher stress as adolescents were more likely to have high blood pressure, obesity, and other cardiometabolic risk factors. This highlights the importance of stress management from an early age to prevent these health issues.
A new study published in Nature Communications found that AI-driven eye exams can close care gaps among racial and ethnic minority youth with diabetes, populations with historically higher rates of diabetic retinopathy. The technology uses cameras to take pictures of the back of the eye without dilation and provides immediate results.
A large-scale ancient human gene bank analysis revealed that genetic variants increasing MS risk were introduced by sheep and cattle herders 5,000 years ago. This finding explains the North-South Gradient of MS prevalence in Europe.
A Cornell University study using lab mice with human genes found that male mice exposed to arsenic developed insulin resistance and Type 2 diabetes, while female mice did not. The researchers identified a biomarker called miR-34a associated with insulin resistance in Type 2 diabetes.
A study by Virginia Tech researchers found that medications used to treat Type 2 diabetes, such as Ozempic and Mounjaro, can decrease cravings for alcohol and lead to reduced consumption in individuals with obesity. The findings add to a growing literature on the potential of GLP-1 agonists to curb dangerous drinking habits.
A recent study found that liraglutide, a GLP-1R agonist, rapidly improves insulin sensitivity in individuals with obesity and pre-diabetes. Insulin sensitivity is crucial for controlling blood glucose levels, and improved sensitivity reduces the risk of developing Type 2 diabetes or improving its treatment.
A new study suggests that US adults consume almost a quarter of their daily calories in snacks, often more than they do at breakfast, yet these snacks offer little nutritional value. Researchers analyzed data from over 20,000 people and found that snacks accounted for between 19.5% to 22.4% of total energy intake.
A Leicester study found that weight cycling is associated with worsening body composition and increased risk of physical health issues. Participants who lost and regained weight experienced a significant loss of muscle mass, while gaining all their lost fat.
A new study by Lund University researchers confirms that epigenetic changes can contribute to the development of type 2 diabetes. The study identified 5584 sites with differing epigenetic changes in individuals with and without the disease, as well as a key gene RHOT1 involved in insulin secretion.